Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.280
-0.070 (-1.61%)
At close: Apr 28, 2026, 4:00 PM EDT
4.400
+0.120 (2.80%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Molecular Partners AG Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Molecular Partners AG stock have an average target of 8.38, with a low estimate of 3.75 and a high estimate of 13. The average target predicts an increase of 95.79% from the current stock price of 4.28.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Molecular Partners AG stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +203.74% | Apr 22, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +203.74% | Mar 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +203.74% | Jan 27, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $4 → $3.75 | Hold | Maintains | $4 → $3.75 | -12.38% | Dec 8, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $4.5 → $4 | Hold | Maintains | $4.5 → $4 | -6.54% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
6.89M
Revenue Next Year
32.64M
from 6.89M
Increased by 374.07%
EPS This Year
-1.37
from -1.65
EPS Next Year
0.23
from -1.37
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 23.1M | 129.2M | ||||||
| Avg | 6.9M | 32.6M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 1,775.8% | ||||||
| Avg | - | 374.1% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.68 | 1.90 | ||||||
| Avg | -1.37 | 0.23 | ||||||
| Low | -1.93 | -1.32 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.